Database
User
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 32.23±2.10 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | human | HepG2 | MMP assay | Negative | IC50 | 163 | ||
| MEMBRANE POTENTIAL | rat | hepatocytes | MMP assay | Negative | IC50 | 163 | ||
| (rs)-1-(4-t-butylbenzyl)-4-(4-chlorobenzhydryl) piperazine dihydrochloride | 1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine dihydrochloride | 1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)-(phenyl)methyl)piperazine dihydrochloride |
| 1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazine dihydrochloride | 1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazinediium dichloride | 1-(p-Chlorobenzhydryl)-4-(p-t-butylbenzyl)diethylenediamine dihydrochloride |
| 1-(p-tert-Butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)piperazine dihydrochloride | 1-(p-tert-Butylbenzyl)-4-(p-chlorodiphenylmethyl)piperazine dihydrochloride | 1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride |
| 1-p-Chlorobenzhydryl-4-p-(t)-butylbenzylpiperazine dihydrochloride | 129-74-8 | 129B748 |
| 163837-35-2 | 163837-36-3 | 4CA-0326 |
| A 7668 | AK-54927 | AKOS016004771 |
| ANW-66382 | API0001773 | AX8118925 |
| Aphilan R | BCP0726000050 | BCP22428 |
| BCP9000459 | BUCLIZINE, DIHYDROCHLORIDE | Bucladin |
| Bucladin S | Bucladin-S | Buclina |
| Buclizine HCl | Buclizine dihydrochloride | Buclizine dihydrochloride, >=98% (HPLC) |
| Buclizine hydrochloride | Buclizine hydrochloride (USAN) | Buclizine hydrochloride [USAN] |
| Buclizine hydrochloride, (+)- | Buclizine hydrochloride, (-)- | C28H33ClN2 |
| C28H33ClN2.2HCl | CAS-129-74-8 | CHEBI:61193 |
| CHEMBL2360580 | CTK8C1377 | D02089 |
| DSSTox_CID_25091 | DSSTox_GSID_45091 | DSSTox_RID_80665 |
| DTXSID5045091 | EINECS 204-962-4 | EOP5593FPH |
| FT-0663892 | Histabutyzine dihydrochloride | Histabutyzine hydrochloride |
| J-005711 | KS-00000FU4 | KS-1250 |
| LS-110573 | Longifene | NCGC00013315-01 |
| NSC 25141 | Perlapine, >=98% (HPLC) | Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride |
| Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride, (+)- | Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride, (-)- | Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, hydrochloride (1:2); |
| Piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)-, dihydrochloride | Postafeno | Q27130875 |
| Q710 | SCHEMBL123751 | ST24037299 |
| Softran | TC-155127 | Tox21_110023 |
| UCB 4445 | UCB-4445 | UNII-EOP5593FPH |
| UNII-V4OCE982YU | V4OCE982YU | Vibazine (TN) |
| Vibazine hydrochloride | buclizine 2HCl | buclizine-hcl |
| s4140 |